In an international collaboration, researchers have made an important breakthrough in the therapeutic delivery of microRNAs ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...

InflaRx will conduct a virtual fireside chat on March 27 at 8:30 AM ET and will participate in one-on-one-investor meetings. A link to register for the fireside chat live stream and its replay is ...

The FDA accepted for priority review a supplemental Biologics License Application for Keytruda for resectable locally ...

LUCY Letby’s former boss thought that she was a “scapegoat” for the hospital’s failings and would be cleared without charge, a former chief executive has claimed. Letby, ...

Every year, 900,000 Americans are caught by surprise by the symptoms of a pulmonary embolism: a sudden shortness of breath, ...

Kiniksa’s actions leave it focused on a cardiovascular disease pipeline led by the IL-1 antagonist KPL-387. The program is ...

The Pregnancy Meeting researchers will unveil findings from a clinical trial in India that suggest that a single dose of iron delivered intravenously early in the second trimester is a safe and ...

The first hemophilia B patient at the Loma Linda University Health Hemophilia Treatment Center to receive Hympavzi is a ...

Clinical data from Indaptus’ ongoing Phase 1 trial evaluating Decoy20 in advanced solid tumors.